Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer disease

Citation
Jj. Claus et al., Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer disease, ALZ DIS A D, 12(3), 1998, pp. 167-174
Citations number
39
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ALZHEIMER DISEASE & ASSOCIATED DISORDERS
ISSN journal
08930341 → ACNP
Volume
12
Issue
3
Year of publication
1998
Pages
167 - 174
Database
ISI
SICI code
0893-0341(199809)12:3<167:SOQSEI>2.0.ZU;2-E
Abstract
The relation between quantitative spectral electroencephalogram (qEEG) para meters and subsequent rate of cognitive, functional, and behavioral decline in 82 consecutive patients with early probable Alzheimer disease (NINCDS-A DRDA criteria) was examined in a prospective study. The qEEG was performed at initial examination and global cognitive function, activities of daily l iving, and behavior were assessed at initial evaluation and after a period of 6 months. Using multiple linear regression analysis,higher frontocentral and parieto-occipital theta values, lower parieto-occipital beta values, a nd lower peak frequency were significantly associated with more decline in global cognitive function over the follow-up period. In addition, lower par ieto-occipital beta values were significantly related to more decline in ac tivities of daily living. These associations were independent of demographi c (age, sex, and education) and disease characteristics [initial Cambridge Examination for Mental Disorders of the Elderly Cognitive test (CAMCOG) or Mini-Mental State Examination scores, estimated duration of symptoms, estim ated prior rate of decline, and dementia severity]. In a separate multiple logistic regression analysis, prediction of rapidly progressive decline, de fined as 8 or more points decline in CAMCOG scores (n = 21), could be made with parieto-occipital and frontocentral beta values. The results suggest t hat slowing on qEEG is a marker for subsequent rate of cognitive and functi onal decline in mildly demented AD patients, independent of demographic or disease characteristics.